Details of Disease

Disease Name

Insulin-dependent diabetes

Disease Class

5A10: Diabetes mellitus

Disease Hierarchy

DIS01GPL: Grass pollen hypersensitivity

DISNFI3F: Insulin-dependent diabetes

ICD-11

ICD-11: 5A10

Expand ICD-11

'5A10

Expand ICD-10

'E10; 'E10.0; 'E10.1; 'E10.2; 'E10.3; 'E10.4; 'E10.5; 'E10.6; 'E10.7; 'E10.8; 'E10.9

Disease Identifiers

MONDO ID

MONDO_0010255

UMLS CUI

C1848042

OMIM ID

300136

MedGen ID

338376

General Information of Disease (ID: DISNFI3F)

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)

This Disease is Treated as An Indication in 5 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
DiabeCell	DMK6FYR	Phase 2	NA	[1]
HinsBet	DM97A5O	Phase 2	NA	[2]
SAR292833	DM63QY0	Phase 2	NA	[3]
Insulin B chain vaccine	DMEQVTK	Phase 1	NA	[4]
NN-1952	DMQO0NC	Phase 1	NA	[5]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 3 Discontinued Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
AnergiX-IDDM	DMNCH8Q	Terminated	NA	[6]
AnervaX.DB	DM894X9	Terminated	NA	[7]
NNC-55-0118	DMC451S	Terminated	Small molecular drug	[8]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 13 Investigative Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
CPG23DIAB	DMXR7E8	Investigative	NA	[3]
CPG23STEM	DMBB93I	Investigative	NA	[3]
EDC/IL-4	DMZBJ2Y	Investigative	NA	[3]
EDP-10	DM0FWQE	Investigative	NA	[3]
Epi-13	DMLGP4I	Investigative	NA	[3]
FT-201	DM4SJW8	Investigative	NA	[3]
GlucoStem	DMN05SZ	Investigative	NA	[3]
GRNIC-1	DM9YVDZ	Investigative	NA	[3]
MCT-275	DMEQCQU	Investigative	NA	[3]
MesoStem	DMALRXV	Investigative	NA	[3]
ReN-002	DM7Y8DZ	Investigative	NA	[3]
RGI-3010	DM20TUF	Investigative	NA	[3]
WIT-301	DM3U5BJ	Investigative	NA	[3]
------------------------------------------------------------------------------------


⏷ Show the Full List of 13 Drug(s)

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1	ClinicalTrials.gov (NCT01736228) Open-label Investigation of the Safety and Efficacy of DIABECELL in Patients With Type 1 Diabetes Mellitus. U.S. National Institutes of Health.
2	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800034744)
3	The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
4	Prevention of Type 1 Diabetes Mellitus using a Novel Vaccine. Ther Adv Endocrinol Metab. 2011 Feb;2(1):9-16.
5	ClinicalTrials.gov (NCT01028404) A Two Part Trial Investigating NN1952 in Healthy Subjects and Subjects With Type 1 and Type 2 Diabetes. U.S. National Institutes of Health.
6	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014923)
7	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010394)
8	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010228)